Reversing epithelial to mesenchymal transition by targeted epigenetic editing in breast cancer

  • Blancafort, Pilar (Primary Chief Investigator (PCI))
  • Gersbach, Charles A. (Chief Investigator (CI))
  • Thompson, Erik W. (Chief Investigator (CI))
  • Swaminatha Iyer, Killugudi L (Chief Investigator (CI))
  • Rots, Marianne (Chief Investigator (CI))
  • Redfern, Andrew (Chief Investigator (CI))
  • Chaffer, Christine (Chief Investigator (CI))
  • Cursons, Joseph (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/20 → 31/12/22

Funding

  • NHMRC - National Health and Medical Research Council (Australia): A$1,333,651.20

Keywords

  • breast cancer
  • epigenetics
  • gene expression
  • biotechnology
  • epithelial-mesenchymal transition (EMT)